Table 3.
Comparison of TXNIP levels and metabolic parameters across PCOS groups with different BMI and control
| Parameter | Ctrl. (n = 102) | OB-PCOS (n = 21) | OW-PCOS (n = 38) | P-value |
|---|---|---|---|---|
| Age (years) | 24.62 ± 4.67 | 25.52 ± 4.09 | 24.84 ± 4.71 | 0.739 |
| AMH (ng/mL) | 8.13 ± 3.17 | 7.28 ± 3.23 | 7.44 ± 3.41 | 0.369 |
| HCY (µmol/L) | 11.83 ± 3.75 | 12.04 ± 3.86 | 11.31 ± 3.59 | 0.702 |
| HOMA-IR | 1.60 ± 1.14 | 4.33 ± 3.04 | 2.75 ± 1.73 | < 0.001 |
| Fins (mU/L) | 7.32 ± 4.68 | 18.46 ± 11.53 | 12.13 ± 6.91 | < 0.001 |
| FBG (mmol/L) | 4.84 ± 0.39 | 5.16 ± 0.69 | 4.95 ± 0.54 | 0.017 |
| CRP (mg/L) | 1.86 ± 2.62 | 3.61 ± 2.97 | 2.52 ± 2.67 | 0.020 |
| TG (mmol/L) | 0.98 ± 0.55 | 1.85 ± 1.04 | 1.43 ± 0.76 | < 0.001 |
| HDL (mmol/L) | 1.60 ± 0.36 | 1.13 ± 0.23 | 1.30 ± 0.26 | < 0.001 |
| LDL (mmol/L) | 2.58 ± 0.72 | 2.91 ± 0.70 | 2.76 ± 0.78 | 0.103 |
| TC (mmol/L) | 4.74 ± 0.84 | 4.92 ± 0.84 | 4.70 ± 0.94 | 0.628 |
| TXNIP (ng/mL) | 0.30 ± 0.07 | 0.38 ± 0.11 | 0.33 ± 0.11 | < 0.001 |
Note: P < 0.05 indicates statistical significance. Data are expressed as mean ± standard deviation
Abbreviations: AMH Anti-Müllerian hormone, HCY Homocysteine, HOMA-IR Homeostatic Model Assessment Index, Fins Fasting insulin, FBG Fasting blood glucose, CRP C-reactive protein, TG Triglycerides, HDL High-density lipoprotein, LDL Low-density lipoprotein, TC Total cholesterol, TXNIP Thioredoxin-interacting protein, OB-PCOS Obese PCOS group, OW-PCOS Overweight PCOS group, CTRL Control group